Topic Highlight
Copyright ©The Author(s) 2015.
World J Gastrointest Oncol. Nov 15, 2015; 7(11): 317-327
Published online Nov 15, 2015. doi: 10.4251/wjgo.v7.i11.317
Table 2 MET mRNA expressions and clinical outcomes in gastric cancer
nOverexpression
Relation to clinicopathological factorsRelation to survivalRef.
Cut-off value%
Tumor100Value determined by nonparametric receiver operating characteristics11MWorse[34]
100ND24NDND[43]
45N, stage, differentiated typeND[35]
43Value of mean + 2 SD in noncancerous tissue70NAND[36]
15Intestinal typeND[22]
Serum52Detected62T, N, M, stage, recurrence, vWorse[37]